We are live on ! Find out more
SPHS

Sophiris Bio, Inc.
SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

Back to rankings

24 hedge funds and large institutions have $40.6M invested in Sophiris Bio, Inc. in 2013 Q3 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+24
Holders Change %
–
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
24
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$7.44M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.6M
3
First Manhattan
First Manhattan
New York
+$4.61M
4
AG
Artal Group
Luxembourg
+$4.61M
5
BI
BVF Inc
California
+$2.77M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$7.54M +$7.44M +1,614,228 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$6.53M +$6.6M +1,431,268 New
GPP
3
Great Point Partners
Connecticut
$5.99M +$5.9M +1,280,000 New
First Manhattan
4
First Manhattan
New York
$4.68M +$4.61M +1,000,500 New
AG
5
Artal Group
Luxembourg
$4.68M +$4.61M +1,000,000 New
BI
6
BVF Inc
California
$2.81M +$2.77M +600,000 New
Franklin Resources
7
Franklin Resources
California
$2.34M +$2.31M +500,000 New
TCM
8
Tang Capital Management
California
$2.34M +$2.31M +500,000 New
First Eagle Investment Management
9
First Eagle Investment Management
New York
$1.17M +$1.15M +250,000 New
Citadel Advisors
10
Citadel Advisors
Florida
$690K +$680K +147,404 New
DM
11
Deerfield Management
New York
$578K +$570K +123,585 New
Deutsche Bank
12
Deutsche Bank
Germany
$345K +$341K +73,961 New
TD Asset Management
13
TD Asset Management
Ontario, Canada
$275K +$271K +58,850 New
PAI
14
Palo Alto Investors
California
$257K +$254K +55,000 New
AII
15
AGF Investments Inc
Ontario, Canada
$148K +$150K +32,554 New
SNC
16
Stifel Nicolaus & Co
Missouri
$84.4K +$83.1K +18,025 New
VKH
17
Virtu KCG Holdings
New York
$51K +$54.2K +11,750 New
Canada Life
18
Canada Life
Manitoba, Canada
$35K +$37.3K +8,087 New
IGIM
19
I.G. Investment Management
Manitoba, Canada
$31K +$31.4K +6,805 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$3K +$2.96K +642 New
AllianceBernstein
21
AllianceBernstein
Tennessee
$2K +$1.77K +383 New
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
$1K +$968 +210 New
Bank of America
23
Bank of America
North Carolina
– +$175 +38 New
Citigroup
24
Citigroup
New York
– +$502 +109 New

SPHS Hedge Fund Activity: Q3 2013 in Review

24 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q3 2013, worth a combined $40.6M.

Buyers outnumbered sellers: 24 funds opened new SPHS positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $7.44M.

  • 24 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q3 2013, up from 0 in Q2 2013.
  • Funds reported $40.6M of Sophiris Bio, Inc. stock for Q3 2013.
  • 24 funds opened new Sophiris Bio, Inc. positions in Q3 2013 and 0 closed out, a net change of +24 holders.
  • The largest Sophiris Bio, Inc. buyer in Q3 2013 was T. Rowe Price Associates, an estimated $7.44M added.

Based on aggregated 13F filings for Q3 2013.